DermNet provides Google Translate, a free machine translation service. Note that this may not provide an exact translation in all languages
Home » Topics A–Z » Mid-dermal elastolysis
Author: Dr Bob Chan, Dermatology Registrar, Auckland, New Zealand, November 2014.
Mid-dermal elastolysis is a rare, acquired skin condition of elastic tissues. Elastic fibres provide skin tissue with elastic recoil and resilience. In mid-dermal elastolysis, there is a selective loss of elastic fibres in the mid-dermis.
Mid-dermal elastolysis has been reported mostly in Caucasian patients, with a female predominance. The most commonly affected sites are the trunk and upper arms; the face and lower legs are only occasionally affected.
There have been 3 clinical subtypes of mid-dermal elastolysis described.
Mid-dermal elastolysis type I
The exact cause of mid-dermal elastolysis is unknown. It is associated with localised increased activity of elastase, an enzyme involved in elastin breakdown.
Reported associations with mid-dermal elastolysis include:
Biopsy features can be helpful to confirm the diagnosis of mid-dermal elastolysis. Specimens may appear normal with haematoxylin and eosin stain (H&E) or may have a discrete inflammatory infiltrate. Band-like or focal loss of elastic fibres can be seen in the mid-dermis with elastic stains.
Mid-dermal elastolysis histopathology
Sun protection is recommended as UV radiation is a possible cause of mid-dermal elastolysis. Topical retinoids may improve the appearance of wrinkling.
Other treatments, including topical and systemic steroids, hydroxychloroquine, vitamin E, clofazimine, and colchicine have not been shown to be beneficial.
See smartphone apps to check your skin.
[Sponsored content]
© 2021 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.